Tracked deals
4
4 tracked deals across 2021-2024.
Public Company
Healthcare
Quest Diagnostics
Secaucus, New Jersey, United States
Quest Diagnostics (NYSE: DGX) provides clinical laboratory testing, anatomic pathology, diagnostic and consultative services, and health information technology solutions that help improve healthcare decisions and outcomes.
- Focus Areas
- Clinical laboratory services, Diagnostic testing, Anatomic pathology
- Website
- www.questdiagnostics.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout
Quest Diagnostics Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
- Buyer
- Quest Diagnostics
- Target
- LifeLabs
- Seller
- OMERS
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Type
- Buyout
Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.
-
April 27, 2023
- Buyer
- Quest Diagnostics
- Target
- Haystack Oncology
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Type
- Buyout
Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.
-
January 18, 2022
- Buyer
- Quest Diagnostics
- Target
- Pack Health
- Industry
- Healthcare Services
- Location
- Alabama, United States
- Type
- Buyout
Quest Diagnostics has entered into a definitive agreement to acquire Pack Health in an all-cash transaction. The acquisition brings Pack Health's patient-engagement platform and certified health coaches into Quest's Extended Care services to strengthen value-based care and connect diagnostic insights to action.
-
December 14, 2021
- Buyer
- Quest Diagnostics
- Target
- Labtech Diagnostics
- Industry
- Healthcare Services
- Location
- South Carolina, United States
- Type
- Buyout
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
Related Acquisition Pages
Selling a company? Get in front of buyers like Quest Diagnostics
Turn tracked acquisition activity into an outreach-ready buyer list.